检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:祝骥[1] 许颖龄[2] 卢德赵[2] 唐利华[2] 赵峻峰[1] 朱雅敏[2] 薛蕾[1] ZHU Ji XU Yingling LU Dezhao TANG Lihua ZHAO Junfeng ZHU Yamin XUE Lel(The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China College of Life Science, Zhejiang Chinese Medical University, Hangzhou 310053, China)
机构地区:[1]浙江中医药大学附属第三医院,杭州310005 [2]浙江中医药大学生命科学学院,杭州310053
出 处:《中国现代应用药学》2016年第12期1503-1507,共5页Chinese Journal of Modern Applied Pharmacy
基 金:浙江省中医药科技计划(2012ZA066);浙江省自然科学基金项目(LY13H270005)
摘 要:目的探讨复方丹参片对颈动脉粥样硬化兔PPAR-γ/LXR-α/ABCA1信号通路的影响。方法高脂饲料加空气干燥法建立兔颈动脉粥样硬化模型,并用100 mg·kg^(-1)和300 mg·kg^(-1)剂量的复方丹参片进行治疗后,经耳缘静脉抽血后空气栓塞处死兔,迅速剥离颈动脉,并检测各组动物血脂含量、颈动脉病理学变化及兔颈动脉中PPAR-γ、LXR-α及ABCA1的表达。结果复方丹参片能显著降低兔血清总胆固醇、三酰甘油、低密度脂蛋白(P<0.01);并能抑制内膜增生,减少脂质沉积,增加PPAR-γ、LXR-α及ABCA1 mRNA及蛋白质的表达(P<0.01)。结论复方丹参片可能通过激活PPAR-γ/LXR-α/ABCA1信号通路而发挥抗动脉粥样硬化作用。OBJECTIVE To illustrate the effect of Fufang Dangshen Pian on PPAR-γ/LXR-α/ABCA1 signaling pathways in atherosclerotic rabbit. METHODS The model of rabbit carotid atherosclerosis were established with the methods of high fat diet and air seasoning, and treated with Fufang Dangshen Pian at 100 mg·kg-(-1) and 300 mg·kg-(-1) concentration. Carotid arteries were quickly stripped after the rabbits killed by air embolism, and the changes of serum lipid levels, pathological changes of carotid artery and the expression of PPAR-γ, LXR-α and ABCA1 in carotid arteries of rabbits were detected. RESULTS The complex tablet significantly reduced the TC, TG, LDL of experimental rabbit. Meanwhile, it reduced lipid accumulation, up-regulated the expression of PPAR-γ, LXR-α, ABCA1 mRNA and protein. CONCLUSION Fufang Dangshen Pian can decrease inhibit the formation of carotid atherosclerosis in experimental rabbit by activateing PPAR-γ/LXR-α/ABCA1 signaling pathways.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.116.42.143